ACO Name and Location

Orange Accountable Care of New York

Previous Names: Total Care ACO, LLC

14750 NW 77th Ct

Suite 308

Miami Lakes, FL 33016

 

ACO Primary Contact

Primary Contact Name	Lissette Exposito RN, BSN, MHSA, Founder, President and CEO
Primary Contact Phone Number	(786) 363-8500
Primary Contact Email Address	Lissette.Exposito@orangecaregroup.com

 

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture
ALAN DITCHEK MD PLLC	N
Aline Benjamin MD	N
American Medical Diagnostics PLLC	N
Ariel Medina	N
Arkadiy Izrailov	N
BABYLON MEDICAL PRACTICE, P.C.	N
BENJAMIN LIFSHITZ MD	N
Bernard Rimler	N
BRIJ M. SHARMA PHYSICIAN P.C	N
C&Y Medical PC	N
DEBORAH RIMLER MD	N
Ezra Israel	N
FRANCINE DIMARIA	N
FREDRIC J MINTZ, MD, PC	N
GARY BECKER	N
HARRY BERKOWITZ	N
I & R MEDICAL SERVICES, PC.	N
JOSEPH GELBFISH	N
Joseph Slomowits, MD	N
KRZYSZTOF SYGNAROWICZ PHYSICIAN PC	N
MARSHA WESLEY	N
MARVIN BECKER	N
MARY MATTHEOS PHYSICIAN, PC	N
MEDICAL CARE PLLC	N
Mitchell E Lipton MD PC	N
MOSHE KATZENELENBOGEN	N
Nabat Medical PC	N
ROBERT HUSNEY M.D.,P.C.	N
SUMAIYAH MEDICAL PC	N
VICTOR TENENBAUM	N

 

ACO governing body:

 

Member Last Name	Member First Name	Member Title/Position	Member’s Voting Power: expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if applicable
Exposito	Lissette	President, CEO, & Board Chair	24%	Board Chair and Voting Member
Rimler, MD	Deborah	Board Member	18.75%	ACO Participant and Voting Member	DEBORAH RIMLER MD
Rimler, MD	Bernard	Board Member	18.75%	ACO Participant and Voting Member	Bernard Rimler
Israel, MD	Roza	Board Member	18.75%	ACO Participant and Voting Member	I & R MEDICAL SERVICES, PC.
Hertz, DO	Jared	Board Member	18.75%	ACO Participant and Voting Member	BABYLON MEDICAL PRACTICE, P.C.
Mook	Sarah	Board Member	1%	ACO Patient and Medicare Beneficiary Representative

 

Key ACO clinical and administrative leadership:

• ACO Executive: Lissette Exposito
• Medical Director: Deborah Rimler, MD
• Compliance Officer: Marc Troisi
• Quality Assurance/Improvement Officer: Pablo Quintela, MD

 

 

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Quality and Informatics	Pablo Quintela, MD, Chair
Patient Experience	Raphael Ruiz, Chair
Finance and Contracting	Frank Exposito, Co-Chair Pablo Quintela, MD, Co-Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

• ACO professionals in a group practice arrangement
• Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses:

• Second Agreement Period
  • Performance Year 2020, $6,383,360
  • Performance Year 2019, $4,905,346
  • Performance Year 2018, $6,935,575
• First Agreement Period

• • Performance Year 2017, $2,804,738
  • Performance Year 2016, $3,242,894
  • Performance Year 2015, $3,304,770

Shared Savings Distribution:

• Second Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2019
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2018
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
• First Agreement Period

• • Performance Year 2017
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%

• • Performance Year 2016
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%

• • Performance Year 2015
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%

 

Quality Performance Results

2020 Quality Performance Results:

ACO #	Measure Name	Rate	ACO Mean
ACO-8 [1]	Risk Standardized, All Condition Readmission	15.92	15.38
ACO-38 [1,2]	Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions	42.95	51.34
ACO-43 [3]	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	0.57	1.69
ACO-13	Falls: Screening for Future Fall Risk	90.80	90.73
ACO-14	Preventive Care and Screening: Influenza Immunization	91.33	76.03
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	96.00	81.67
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-up Plan	82.28	71.46
ACO-19	Colorectal Cancer Screening	87.65	72.59
ACO-20	Breast Cancer Screening	80.21	74.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	89.76	83.37
ACO-40	Depression Remission at Twelve Months	71.56	13.99
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	8.75	14.70
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	82.07	72.87

 

 

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.